Stabicon - Incisive Solution, Decisive Results

7th IPA ACG-SCITECH INNOVATION AWARDS 2020

Stabicon Life Sciences, a pioneer in development of OTC / Natural products, was honoured with Best Innovative Development of Solid Dosage Form Award in the industry 2020 by IPA-ACG SCITECH. The award was conferred during the 72nd IPC held at Nagpur on 21st January 2023. The award consists of a memento and a cash prize of INR 1,00,000/-. Indian Pharmaceutical Association(IPA) is the apex body of pharmaceutical scientists and technologies in India. ACG SCITECH is promoted by largest manufacturer of hard gelatin empty capsules in India named Associated Capsule Group. ACG SCITECH is the initiator of this award.

Stabicon had nominated its Nanotechnology based highly soluble oral drops for the 7th IPA-ACG SCITECH Innovation Awards in December 2020. The oral route is the most common and cost effective route for drug administration. Nevertheless, oral administration is limited by difficulties related to the physicochemical properties of the drug molecule, including low aqueous solubility, instability, low permeability, and rapid metabolism, all of which result in low and irregular oral bioavailability. Mother nature provides everything to fight disease and we need right product to fight new diseases. Curcumin (Diferuloylmethane) is a polyphenolic compound extracted from “Golden spice” Turmeric (Curcuma longa) having plethora of scientifically proven health benefits for the treatment of many diseases. However, curcumin’s full potential has not been achieved due to its poor solubility, poor bioavailability, chemical instability and crystalline nature.

Stabicon R&D had developed globally patented C3 Cura^TM* augmented absorption technology. The novel micelle technology helps to prepare stable curcumin nanoparticle drops with improved therapeutic efficacy. It helps in 100% solubility and 500 times more bioavailability of Curcumin. This claim has been validated by in vitro and in vivo studies. The increased bioavailability helps to reduce the dose of Curcumin to 1/100th. Stabicon is adding science to the ancient Indian wisdom for better efficacy so that small dose provides the same effect of normal dose also devoid of undesirable side effects.

The nano drops are absorbed in pharmaceutically acceptable excipients and made them into various solid dosage forms without losing their nano properties. C3 CuraTM* patented technology opens up to plethora of therapeutic application of Curcumin. It will a quantum leap in pharma industry especially in Indian Pharma industry.

*GLOBAL TECHNOLOGY PATENT APPLIED - International Publication Number: WO 2020/084634 A1

The function was attended by the fellows of IPA, industry leaders, regulators, educators and healthcare professionals.

Mr. Ajit Singh (Chairman – ACG worldwide), Dr. T. V. Narayana (National President – IPA), Mr. Suresh Khanna (Hon. General Secretary – IPA) and Mr. Andrew (Ex. Hon. President – IPA) were invited to present the IPA-ACG SCITECH Innovation Awards.